CHICAGO, July 12, 2022 /PRNewswire/ According to the new market research report "3D Bioprinting Market by Component (3D Bioprinters (Microextrusion, Inkjet, Laser, Magnetic), Bioink (Natural
3D Printing Medical Devices Market worth $5.1 billion by 2026 - Exclusive Report by MarketsandMarkets 3D Printing Medical Devices Market by Component (3D Printer, 3D Bioprinter, Material, Software, Service), Technology (EBM, DMLS, SLS, SLA, DLP, Polyjet), Application (Surgical Guides, Prosthetics, Implants), User (Hospital, ASCs) - Global Forecast to 2026 , published by MarketsandMarkets, the global market is projected to reach USD 5.1 billion by 2026 from USD 2.4 billion in 2021, at a CAGR of 16.3% during the forecast period.
Browse in-depth TOC on
543 - Tables
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90799911
The growth of this market is mainly driven by the growing number of 3D printer vendors across major markets, increasing adoption of patient-specific medical devices. Moreover, rising R&D investments by the key players operating in the market to develop advanced 3D Printing Medical Devices coupled with growing funding & grants for
Human Organoids Market worth $1,901 million by 2025 - Exclusive Report by MarketsandMarkets Human Organoids Market by Product (Pancreas, Kidney, Lung, GIT, Liver Models) Usabilty (Customized, Ready-To-Use), Application (Toxicity, Pathology, Personalized & Regenerative Medicine), Enduser (Pharma-Biotech, CROs, Academia) & Region- Global Forecast to 2025 , published by MarketsandMarkets, the Human Organoids Market is estimated to be USD 850 million in 2020 and projected to reach USD 1,901 million by 2025, at a CAGR of 17.5%.
Browse in-depth TOC on
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171046468
The Increasing prevalence of transplantation, technological advancements and increased funding and public-private investments are the key factors driving the growth of the human organoids.